False Claims

Advancing false-claims allegations that pharmaceutical companies paid kickbacks to providers that prescribe its anti-inflammatory drug, a <a href="http://www.courthousenews.com/wp-content/uploads/2019/04/False-claims.pdf"><strong>federal judge found</strong></a> that one could conclude the government's "true motivation [in moving to dismiss] is animus toward the relator."

SPRINGFIELD, Ill. — Advancing false-claims allegations that pharmaceutical companies paid kickbacks to providers that prescribe its anti-inflammatory drug, a federal judge found that one could conclude the government’s “true motivation [in moving to dismiss] is animus toward the relator.”

Categories / Business, Government, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.